期刊文献+

Survivin siRNA/叶酸偶联O-羧甲基壳聚糖纳米粒的制备 被引量:1

Preparation of Survivin siRNA/Folate Conjugated O-Carboxymethyl Chitosan Nanoparticles
下载PDF
导出
摘要 利用叶酸(FA)活性酯与O-羧甲基壳聚糖(O-CMC)合成了具有一定肿瘤靶向性的FA偶联O-CMC(FA-O-CMC),用核磁共振(1H-NMR)对其结构进行了表征。采用离子交联法,以CaCl2为交联剂,制得了Survivin siRNA/FA-O-CMC纳米粒。扫描电镜(SEM)、激光粒度仪和紫外-可见光谱等分析结果表明,纳米粒分散均匀,当CaCl2∶FA-O-CMC和siR-NA∶FA-O-CMC质量比分别为1∶5和1∶400时,纳米粒粒径为(199.5±23.5)nm,Zeta电位为(-17.39±2.16)mV,包封率和载药量分别为(88.96±1.53)%和(38.25±1.33)%,体外释放实验中,72 h基因释放75%,具有良好缓释性能。 Folate conjugated O-carboxymethyl chitosan (FA-O-CMC) possessing tumor targeting was synthesized via FA-ester and O-CMC, and the structure was confirmed by 1H-NMR spectroscopy. Survivin siRNA encapsulated FA-O-CMC nanoparticles were prepared through a cross-linking approach with CaC12. The results of scanning electron microscope (SEM), laser particle size analysis and UV spectra show that the prepared particles are homogeneously dispersed with small particles size (199.5 ± 23.5 nm) and the Zeta potential is (-17.39 ± 2.16) mV when the mass ratios of CaCl2 and siRNA to FA-O-CMC is selected as 1:5 and 1:400. Up to (88.96 ± 1.53) % of the encapsulation efficiency and (38.25 ± 1.33) % of the yield have been achieved to the Survivin siRNA gene. In vitro release shows, 75 % of Survivin siRNA is released after 72 h, exlibiting good controlled release property.
出处 《高分子材料科学与工程》 EI CAS CSCD 北大核心 2012年第5期133-136,共4页 Polymer Materials Science & Engineering
基金 国家自然科学基金资助项目(30672299) 中央高校基本科研业务费资助(CDJXS10220008)
关键词 叶酸 O-羧甲基壳聚糖 纳米粒 SIRNA 基因治疗 folate O-carboxymethyl chitosan nanoparticles siRNA gene therapy
  • 相关文献

参考文献7

  • 1Anitha A, Divya Rani V V,Kfishna R, et al. Synthesis, characterization, cytotoxicity and antibacterial studies of chitosan, O- carboxymethyl and N, O-earboxymethyl chitosan nanoparticles [ J ]. Carbohyd. Polym., 2009, 78: 672-677.
  • 2Zhao X B, Lee R J. Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor[J ]. Adv. Drug Delivery Rev., 2004, 56: 1193-1204.
  • 3Theti D S, Jackrnan A L. The role of a-folate receptor-mediated transport in the antitumor activity of antifolate drugs [J ]. Clin. Cancer Res., 2004, 10: 1080-1089.
  • 4Chan P, Kurisawa M, Chung J E, et al. Synthesis and characterization of chitosan-g-poly (ethylene glycol)- rotate as a non- viral carrier for tumor-targeted gene delivery[J ]. Biomaterials, 2007, 28 : 540-549.
  • 5Basarkar A, Devineni D, Palaniappan R, et al. Preparation, characterization, cytotoxieity and transfection efficiency of poly (DL- lactide-co- glycolide) and poly (DL- lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA[J]. Int. J. Pharm. , 2007, 343 : 247-254.
  • 6Wan A J, Sun Y, Li H L. Characterization of folate-graft- ehitosan as a scaffold for nitric oxide release[J]. Int. J. Biol. Macromol. , 2008, 43: 415-421.
  • 7Lu Y J, Low P S. Folate-mediated delivery of macromoleeular anticancer therapeutic agents[J]. Adv. Drug Deliver. Rev., 2002, 54 : 675-693.

同被引文献24

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部